Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment

Published:2024-02-10 Issue:3 Volume:10 Page:579-594
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Chen Huang¹²^ORCID,Bian Aiwu¹²,Zhou Wenbo¹²,Miao Ying¹,Ye Jiangnan¹,Li Jiahui³,He Peng¹^ORCID,Zhang Qiansen¹^ORCID,Sun Yue¹,Sun Zhenliang³,Ti Chaowen¹,Chen Yihua¹^ORCID,Yi Zhengfang¹^ORCID,Liu Mingyao¹²^ORCID

Affiliation:

1. Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, P.R. China

2. Shanghai Yuyao Biotech Co., LTD. Shanghai 200241, China

3. Southern Medical University Affiliated Fengxian Hospital, Shanghai 201499, China

Funder

East China Normal University

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shanghai Rising-Star Program

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acscentsci.3c01440

Reference62 articles.

1. STATs in cancer inflammation and immunity: a leading role for STAT3

2. Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map

3. Do STAT3 inhibitors have potential in the future for cancer therapy?

4. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation

5. Function of Mitochondrial Stat3 in Cellular Respiration

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the underlying mechanisms of Danshen-Shanzha Decoction on coronary heart disease: An integrated analysis combining pharmacoinformatics and experimental validation;Journal of Ethnopharmacology;2025-01

2. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09

3. Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3;Bioorganic Chemistry;2024-09

4. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

5. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level;European Journal of Medicinal Chemistry;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3